Loading...
MedAvail Holdings, Inc.
MDVLQ•PNK
Healthcare
Medical - Pharmaceuticals
$0.00
$0.00(0.00%)

Over the last four quarters, MedAvail Holdings, Inc.'s revenue moved from $11.46M in Q3 2022 to $405000.00 in Q2 2023. Operating income in Q2 2023 was -$4.45M, with a strong operating margin of -1100%. Despite fluctuations in R&D and SG&A expenses, EBITDA for MedAvail Holdings, Inc. remained robust at -$4.92M, reflecting operational efficiency. Net income rose to -$5.79M, with an EPS of -$3.22. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan